114 related articles for article (PubMed ID: 20378736)
21. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
22. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
[TBL] [Abstract][Full Text] [Related]
23. The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.
Liechti ME; Vollenweider FX
J Psychopharmacol; 2000; 14(3):269-74. PubMed ID: 11106307
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
25. No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA.
Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME
Eur J Clin Pharmacol; 2018 Mar; 74(3):275-283. PubMed ID: 29198060
[TBL] [Abstract][Full Text] [Related]
26. Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.
Schmid Y; Rickli A; Schaffner A; Duthaler U; Grouzmann E; Hysek CM; Liechti ME
J Pharmacol Exp Ther; 2015 Apr; 353(1):102-11. PubMed ID: 25655950
[TBL] [Abstract][Full Text] [Related]
27. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Freedman RR; Johanson CE; Tancer ME
Psychopharmacology (Berl); 2005 Dec; 183(2):248-56. PubMed ID: 16163516
[TBL] [Abstract][Full Text] [Related]
28. Stimulant effects of 3,4-methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal.
Ramaekers JG; Kuypers KP; Samyn N
Addiction; 2006 Nov; 101(11):1614-21. PubMed ID: 17034441
[TBL] [Abstract][Full Text] [Related]
29. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.
Peiró AM; Farré M; Roset PN; Carbó M; Pujadas M; Torrens M; Camí J; de la Torre R
Psychopharmacology (Berl); 2013 Feb; 225(4):883-93. PubMed ID: 23142957
[TBL] [Abstract][Full Text] [Related]
30. Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
Sprague JE; Brutcher RE; Mills EM; Caden D; Rusyniak DE
Br J Pharmacol; 2004 Jun; 142(4):667-70. PubMed ID: 15159279
[TBL] [Abstract][Full Text] [Related]
31. Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
Harris DS; Baggott M; Mendelson JH; Mendelson JE; Jones RT
Psychopharmacology (Berl); 2002 Aug; 162(4):396-405. PubMed ID: 12172693
[TBL] [Abstract][Full Text] [Related]
32. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
Ishibashi T; Mitomi A; Tatebe S; Imai S
Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
[TBL] [Abstract][Full Text] [Related]
33. An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution.
Sugimura M; Hirota Y; Shibutani T; Niwa H; Hori T; Kim Y; Matsuura H
Anesth Prog; 1995; 42(2):29-35. PubMed ID: 8934951
[TBL] [Abstract][Full Text] [Related]
34. beta-blockade, atrial natriuretic peptide and exercise.
Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
[TBL] [Abstract][Full Text] [Related]
35. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.
Dumont GJ; Sweep FC; van der Steen R; Hermsen R; Donders AR; Touw DJ; van Gerven JM; Buitelaar JK; Verkes RJ
Soc Neurosci; 2009; 4(4):359-66. PubMed ID: 19562632
[TBL] [Abstract][Full Text] [Related]
36. Human Pharmacology of Mephedrone in Comparison with MDMA.
Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
[TBL] [Abstract][Full Text] [Related]
37. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
[TBL] [Abstract][Full Text] [Related]
38. [Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers].
Imai H; Niwa M; Nozaki M; Tsurumi K; Fujimura H
Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):13-20. PubMed ID: 6133820
[TBL] [Abstract][Full Text] [Related]
39. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
Channer KS; James MA; MacConnell T; Rees JR
Br J Clin Pharmacol; 1994 Jan; 37(1):53-7. PubMed ID: 7908532
[TBL] [Abstract][Full Text] [Related]
40. Gender differences in the subjective effects of MDMA.
Liechti ME; Gamma A; Vollenweider FX
Psychopharmacology (Berl); 2001 Mar; 154(2):161-8. PubMed ID: 11314678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
